Lung Cancer Screening Software Market Size, Share, Trends, Growth and Forecast 2034

Lung Cancer Screening Software Market

Lung Cancer Screening Software Market By Mode of Delivery (On-Premises, Cloud-Based, and Web-Based), By Product (Nodule Management Software, Lung Cancer Screening Radiology Solution, Pathology and Cancer Staging, Lung Cancer Screening Patient Management Software, Patient Coordination and Workflow, Practice Management, Lung Nodule Computer Aided Detection, and Others), By Application (Small Cell Lung Cancer (SCLC) and Non-Small Cell Lung Cancer (NSCLC)), By Platform (Integrated and Standalone), By End-User (Ambulatory Surgical Centers, Hospitals, Oncology Centers, and Others), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Healthcare Report Format : PDF Pages: 228 Report Code: ZMR-10605 Published Date: May-2026 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 159.29 Million USD 650.4 Million 16.63% 2024

Table Of Content

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Lung Cancer Screening Software Market, (2025 - 2034) (USD Million)
    • 2.2 Global Lung Cancer Screening Software Market : snapshot
  • Chapter 3. Global Lung Cancer Screening Software Market - Industry Analysis
    • 3.1 Lung Cancer Screening Software Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Emphasis on early cancer detection to promote market expansion trends in the future
    • 3.3 Market Restraints
      • 3.3.1. The most prominent growth barrier in the lung cancer screening software market
    • 3.4 Market Opportunities
      • 3.4.1. Ongoing technological advancements are reported in the market to generate growth opportunities
    • 3.5 Market Challenges
      • 3.5.1. The lack of skilled professionals and regulatory hurdles challenge the lung cancer screening software market expansion
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Mode of Delivery
      • 3.7.2 Market attractiveness analysis By Product
      • 3.7.3 Market attractiveness analysis By Application
      • 3.7.4 Market attractiveness analysis By Platform
      • 3.7.5 Market attractiveness analysis By End-User
  • Chapter 4. Global Lung Cancer Screening Software Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Lung Cancer Screening Software Market: company market share, 2024
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Lung Cancer Screening Software Market - Mode of Delivery Analysis
    • 5.1 Global Lung Cancer Screening Software Market overview: By Mode of Delivery
      • 5.1.1 Global Lung Cancer Screening Software Market share, By Mode of Delivery, 2024 and 2034
    • 5.2 On-Premises
      • 5.2.1 Global Lung Cancer Screening Software Market by On-Premises, 2025 - 2034 (USD Million)
    • 5.3 Cloud-Based
      • 5.3.1 Global Lung Cancer Screening Software Market by Cloud-Based, 2025 - 2034 (USD Million)
    • 5.4 Web-Based
      • 5.4.1 Global Lung Cancer Screening Software Market by Web-Based, 2025 - 2034 (USD Million)
  • Chapter 6. Global Lung Cancer Screening Software Market - Product Analysis
    • 6.1 Global Lung Cancer Screening Software Market overview: By Product
      • 6.1.1 Global Lung Cancer Screening Software Market share, By Product, 2024 and 2034
    • 6.2 Nodule Management Software
      • 6.2.1 Global Lung Cancer Screening Software Market by Nodule Management Software, 2025 - 2034 (USD Million)
    • 6.3 Lung Cancer Screening Radiology Solution
      • 6.3.1 Global Lung Cancer Screening Software Market by Lung Cancer Screening Radiology Solution, 2025 - 2034 (USD Million)
    • 6.4 Pathology and Cancer Staging
      • 6.4.1 Global Lung Cancer Screening Software Market by Pathology and Cancer Staging, 2025 - 2034 (USD Million)
    • 6.5 Lung Cancer Screening Patient Management Software
      • 6.5.1 Global Lung Cancer Screening Software Market by Lung Cancer Screening Patient Management Software, 2025 - 2034 (USD Million)
    • 6.6 Patient Coordination and Workflow
      • 6.6.1 Global Lung Cancer Screening Software Market by Patient Coordination and Workflow, 2025 - 2034 (USD Million)
    • 6.7 Practice Management
      • 6.7.1 Global Lung Cancer Screening Software Market by Practice Management, 2025 - 2034 (USD Million)
    • 6.8 Lung Nodule Computer Aided Detection
      • 6.8.1 Global Lung Cancer Screening Software Market by Lung Nodule Computer Aided Detection, 2025 - 2034 (USD Million)
    • 6.9 Others
      • 6.9.1 Global Lung Cancer Screening Software Market by Others, 2025 - 2034 (USD Million)
  • Chapter 7. Global Lung Cancer Screening Software Market - Application Analysis
    • 7.1 Global Lung Cancer Screening Software Market overview: By Application
      • 7.1.1 Global Lung Cancer Screening Software Market share, By Application, 2024 and 2034
    • 7.2 Small Cell Lung Cancer (SCLC)
      • 7.2.1 Global Lung Cancer Screening Software Market by Small Cell Lung Cancer (SCLC), 2025 - 2034 (USD Million)
    • 7.3 Non-Small Cell Lung Cancer (NSCLC)
      • 7.3.1 Global Lung Cancer Screening Software Market by Non-Small Cell Lung Cancer (NSCLC), 2025 - 2034 (USD Million)
  • Chapter 8. Global Lung Cancer Screening Software Market - Platform Analysis
    • 8.1 Global Lung Cancer Screening Software Market overview: By Platform
      • 8.1.1 Global Lung Cancer Screening Software Market share, By Platform, 2024 and 2034
    • 8.2 Integrated
      • 8.2.1 Global Lung Cancer Screening Software Market by Integrated, 2025 - 2034 (USD Million)
    • 8.3 Standalone
      • 8.3.1 Global Lung Cancer Screening Software Market by Standalone, 2025 - 2034 (USD Million)
  • Chapter 9. Global Lung Cancer Screening Software Market - End-User Analysis
    • 9.1 Global Lung Cancer Screening Software Market overview: By End-User
      • 9.1.1 Global Lung Cancer Screening Software Market share, By End-User, 2024 and 2034
    • 9.2 Ambulatory Surgical Centers
      • 9.2.1 Global Lung Cancer Screening Software Market by Ambulatory Surgical Centers, 2025 - 2034 (USD Million)
    • 9.3 Hospitals
      • 9.3.1 Global Lung Cancer Screening Software Market by Hospitals, 2025 - 2034 (USD Million)
    • 9.4 Oncology Centers
      • 9.4.1 Global Lung Cancer Screening Software Market by Oncology Centers, 2025 - 2034 (USD Million)
    • 9.5 Others
      • 9.5.1 Global Lung Cancer Screening Software Market by Others, 2025 - 2034 (USD Million)
  • Chapter 10. Lung Cancer Screening Software Market - Regional Analysis
    • 10.1 Global Lung Cancer Screening Software Market Regional Overview
    • 10.2 Global Lung Cancer Screening Software Market Share, by Region, 2024 & 2034 (USD Million)
    • 10.3. North America
      • 10.3.1 North America Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
        • 10.3.1.1 North America Lung Cancer Screening Software Market, by Country, 2025 - 2034 (USD Million)
    • 10.4 North America Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034
      • 10.4.1 North America Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034 (USD Million)
    • 10.5 North America Lung Cancer Screening Software Market, by Product, 2025 - 2034
      • 10.5.1 North America Lung Cancer Screening Software Market, by Product, 2025 - 2034 (USD Million)
    • 10.6 North America Lung Cancer Screening Software Market, by Application, 2025 - 2034
      • 10.6.1 North America Lung Cancer Screening Software Market, by Application, 2025 - 2034 (USD Million)
    • 10.7 North America Lung Cancer Screening Software Market, by Platform, 2025 - 2034
      • 10.7.1 North America Lung Cancer Screening Software Market, by Platform, 2025 - 2034 (USD Million)
    • 10.8 North America Lung Cancer Screening Software Market, by End-User, 2025 - 2034
      • 10.8.1 North America Lung Cancer Screening Software Market, by End-User, 2025 - 2034 (USD Million)
    • 10.4. Europe
      • 10.4.2 Europe Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
        • 10.4.2.1 Europe Lung Cancer Screening Software Market, by Country, 2025 - 2034 (USD Million)
    • 10.4 Europe Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034
      • 10.4.1 Europe Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034 (USD Million)
    • 10.5 Europe Lung Cancer Screening Software Market, by Product, 2025 - 2034
      • 10.5.1 Europe Lung Cancer Screening Software Market, by Product, 2025 - 2034 (USD Million)
    • 10.6 Europe Lung Cancer Screening Software Market, by Application, 2025 - 2034
      • 10.6.1 Europe Lung Cancer Screening Software Market, by Application, 2025 - 2034 (USD Million)
    • 10.7 Europe Lung Cancer Screening Software Market, by Platform, 2025 - 2034
      • 10.7.1 Europe Lung Cancer Screening Software Market, by Platform, 2025 - 2034 (USD Million)
    • 10.8 Europe Lung Cancer Screening Software Market, by End-User, 2025 - 2034
      • 10.8.1 Europe Lung Cancer Screening Software Market, by End-User, 2025 - 2034 (USD Million)
    • 10.5. Asia Pacific
      • 10.5.3 Asia Pacific Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
        • 10.5.3.1 Asia Pacific Lung Cancer Screening Software Market, by Country, 2025 - 2034 (USD Million)
    • 10.4 Asia Pacific Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034
      • 10.4.1 Asia Pacific Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034 (USD Million)
    • 10.5 Asia Pacific Lung Cancer Screening Software Market, by Product, 2025 - 2034
      • 10.5.1 Asia Pacific Lung Cancer Screening Software Market, by Product, 2025 - 2034 (USD Million)
    • 10.6 Asia Pacific Lung Cancer Screening Software Market, by Application, 2025 - 2034
      • 10.6.1 Asia Pacific Lung Cancer Screening Software Market, by Application, 2025 - 2034 (USD Million)
    • 10.7 Asia Pacific Lung Cancer Screening Software Market, by Platform, 2025 - 2034
      • 10.7.1 Asia Pacific Lung Cancer Screening Software Market, by Platform, 2025 - 2034 (USD Million)
    • 10.8 Asia Pacific Lung Cancer Screening Software Market, by End-User, 2025 - 2034
      • 10.8.1 Asia Pacific Lung Cancer Screening Software Market, by End-User, 2025 - 2034 (USD Million)
    • 10.6. Latin America
      • 10.6.4 Latin America Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
        • 10.6.4.1 Latin America Lung Cancer Screening Software Market, by Country, 2025 - 2034 (USD Million)
    • 10.4 Latin America Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034
      • 10.4.1 Latin America Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034 (USD Million)
    • 10.5 Latin America Lung Cancer Screening Software Market, by Product, 2025 - 2034
      • 10.5.1 Latin America Lung Cancer Screening Software Market, by Product, 2025 - 2034 (USD Million)
    • 10.6 Latin America Lung Cancer Screening Software Market, by Application, 2025 - 2034
      • 10.6.1 Latin America Lung Cancer Screening Software Market, by Application, 2025 - 2034 (USD Million)
    • 10.7 Latin America Lung Cancer Screening Software Market, by Platform, 2025 - 2034
      • 10.7.1 Latin America Lung Cancer Screening Software Market, by Platform, 2025 - 2034 (USD Million)
    • 10.8 Latin America Lung Cancer Screening Software Market, by End-User, 2025 - 2034
      • 10.8.1 Latin America Lung Cancer Screening Software Market, by End-User, 2025 - 2034 (USD Million)
    • 10.7. The Middle-East and Africa
      • 10.7.5 The Middle-East and Africa Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
        • 10.7.5.1 The Middle-East and Africa Lung Cancer Screening Software Market, by Country, 2025 - 2034 (USD Million)
    • 10.4 The Middle-East and Africa Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034
      • 10.4.1 The Middle-East and Africa Lung Cancer Screening Software Market, by Mode of Delivery, 2025 - 2034 (USD Million)
    • 10.5 The Middle-East and Africa Lung Cancer Screening Software Market, by Product, 2025 - 2034
      • 10.5.1 The Middle-East and Africa Lung Cancer Screening Software Market, by Product, 2025 - 2034 (USD Million)
    • 10.6 The Middle-East and Africa Lung Cancer Screening Software Market, by Application, 2025 - 2034
      • 10.6.1 The Middle-East and Africa Lung Cancer Screening Software Market, by Application, 2025 - 2034 (USD Million)
    • 10.7 The Middle-East and Africa Lung Cancer Screening Software Market, by Platform, 2025 - 2034
      • 10.7.1 The Middle-East and Africa Lung Cancer Screening Software Market, by Platform, 2025 - 2034 (USD Million)
    • 10.8 The Middle-East and Africa Lung Cancer Screening Software Market, by End-User, 2025 - 2034
      • 10.8.1 The Middle-East and Africa Lung Cancer Screening Software Market, by End-User, 2025 - 2034 (USD Million)
  • Chapter 11. Company Profiles
    • 11.1 MRS Systems Inc.
      • 11.1.1 Overview
      • 11.1.2 Financials
      • 11.1.3 Product Portfolio
      • 11.1.4 Business Strategy
      • 11.1.5 Recent Developments
    • 11.2 Nuance Communications Inc.
      • 11.2.1 Overview
      • 11.2.2 Financials
      • 11.2.3 Product Portfolio
      • 11.2.4 Business Strategy
      • 11.2.5 Recent Developments
    • 11.3 Siemens Healthineers AG
      • 11.3.1 Overview
      • 11.3.2 Financials
      • 11.3.3 Product Portfolio
      • 11.3.4 Business Strategy
      • 11.3.5 Recent Developments
    • 11.4 Eon
      • 11.4.1 Overview
      • 11.4.2 Financials
      • 11.4.3 Product Portfolio
      • 11.4.4 Business Strategy
      • 11.4.5 Recent Developments
    • 11.5 MagView
      • 11.5.1 Overview
      • 11.5.2 Financials
      • 11.5.3 Product Portfolio
      • 11.5.4 Business Strategy
      • 11.5.5 Recent Developments
    • 11.6 Medtronic
      • 11.6.1 Overview
      • 11.6.2 Financials
      • 11.6.3 Product Portfolio
      • 11.6.4 Business Strategy
      • 11.6.5 Recent Developments
    • 11.7 GE HealthCare Technologies Inc.
      • 11.7.1 Overview
      • 11.7.2 Financials
      • 11.7.3 Product Portfolio
      • 11.7.4 Business Strategy
      • 11.7.5 Recent Developments
    • 11.8 Coreline Soft Co. Ltd.
      • 11.8.1 Overview
      • 11.8.2 Financials
      • 11.8.3 Product Portfolio
      • 11.8.4 Business Strategy
      • 11.8.5 Recent Developments
    • 11.9 Koninklijke Philips N.V.
      • 11.9.1 Overview
      • 11.9.2 Financials
      • 11.9.3 Product Portfolio
      • 11.9.4 Business Strategy
      • 11.9.5 Recent Developments
    • 11.10 FUJIFILM Holdings Corporation
      • 11.10.1 Overview
      • 11.10.2 Financials
      • 11.10.3 Product Portfolio
      • 11.10.4 Business Strategy
      • 11.10.5 Recent Developments
    • 11.11 VoxelCloud
      • 11.11.1 Overview
      • 11.11.2 Financials
      • 11.11.3 Product Portfolio
      • 11.11.4 Business Strategy
      • 11.11.5 Recent Developments
    • 11.12 Optellum Ltd
      • 11.12.1 Overview
      • 11.12.2 Financials
      • 11.12.3 Product Portfolio
      • 11.12.4 Business Strategy
      • 11.12.5 Recent Developments
    • 11.13 HealthMyne
      • 11.13.1 Overview
      • 11.13.2 Financials
      • 11.13.3 Product Portfolio
      • 11.13.4 Business Strategy
      • 11.13.5 Recent Developments
    • 11.14 Qure.ai
      • 11.14.1 Overview
      • 11.14.2 Financials
      • 11.14.3 Product Portfolio
      • 11.14.4 Business Strategy
      • 11.14.5 Recent Developments
    • 11.15 PenRad Technologies Inc.
      • 11.15.1 Overview
      • 11.15.2 Financials
      • 11.15.3 Product Portfolio
      • 11.15.4 Business Strategy
      • 11.15.5 Recent Developments
    • 11.16 and others.
      • 11.16.1 Overview
      • 11.16.2 Financials
      • 11.16.3 Product Portfolio
      • 11.16.4 Business Strategy
      • 11.16.5 Recent Developments

Table Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Lung Cancer Screening Software Market attractiveness, By Mode of Delivery
  • 6. Global Lung Cancer Screening Software Market attractiveness, By Product
  • 7. Global Lung Cancer Screening Software Market attractiveness, By Application
  • 8. Global Lung Cancer Screening Software Market attractiveness, By Platform
  • 9. Global Lung Cancer Screening Software Market attractiveness, By End-User
  • 10. Global Lung Cancer Screening Software Market share by Mode of Delivery, 2025 and 2034 (USD Million)
  • 11. Global Lung Cancer Screening Software Market by On-Premises, 2025 - 2034 (USD Million)
  • 12. Global Lung Cancer Screening Software Market by Cloud-Based, 2025 - 2034 (USD Million)
  • 13. Global Lung Cancer Screening Software Market by Web-Based, 2025 - 2034 (USD Million)
  • 14. Global Lung Cancer Screening Software Market share by Product, 2025 and 2034 (USD Million)
  • 15. Global Lung Cancer Screening Software Market by Nodule Management Software, 2025 - 2034 (USD Million)
  • 16. Global Lung Cancer Screening Software Market by Lung Cancer Screening Radiology Solution, 2025 - 2034 (USD Million)
  • 17. Global Lung Cancer Screening Software Market by Pathology and Cancer Staging, 2025 - 2034 (USD Million)
  • 18. Global Lung Cancer Screening Software Market by Lung Cancer Screening Patient Management Software, 2025 - 2034 (USD Million)
  • 19. Global Lung Cancer Screening Software Market by Patient Coordination and Workflow, 2025 - 2034 (USD Million)
  • 20. Global Lung Cancer Screening Software Market by Practice Management, 2025 - 2034 (USD Million)
  • 21. Global Lung Cancer Screening Software Market by Lung Nodule Computer Aided Detection, 2025 - 2034 (USD Million)
  • 22. Global Lung Cancer Screening Software Market by Others, 2025 - 2034 (USD Million)
  • 23. Global Lung Cancer Screening Software Market share by Application, 2025 and 2034 (USD Million)
  • 24. Global Lung Cancer Screening Software Market by Small Cell Lung Cancer (SCLC), 2025 - 2034 (USD Million)
  • 25. Global Lung Cancer Screening Software Market by Non-Small Cell Lung Cancer (NSCLC), 2025 - 2034 (USD Million)
  • 26. Global Lung Cancer Screening Software Market share by Platform, 2025 and 2034 (USD Million)
  • 27. Global Lung Cancer Screening Software Market by Integrated, 2025 - 2034 (USD Million)
  • 28. Global Lung Cancer Screening Software Market by Standalone, 2025 - 2034 (USD Million)
  • 29. Global Lung Cancer Screening Software Market share by End-User, 2025 and 2034 (USD Million)
  • 30. Global Lung Cancer Screening Software Market by Ambulatory Surgical Centers, 2025 - 2034 (USD Million)
  • 31. Global Lung Cancer Screening Software Market by Hospitals, 2025 - 2034 (USD Million)
  • 32. Global Lung Cancer Screening Software Market by Oncology Centers, 2025 - 2034 (USD Million)
  • 33. Global Lung Cancer Screening Software Market by Others, 2025 - 2034 (USD Million)
  • 34. Global Lung Cancer Screening Software Market share, by Region, 2025 and 2034
  • 35. North America Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
  • 36. Europe Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
  • 37. Asia Pacific Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
  • 38. Latin America Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)
  • 39. The Middle-East and Africa Lung Cancer Screening Software Market, 2025 - 2034 (USD Million)

Table Of Tables

  • 1. Global Lung Cancer Screening Software Market: Snapshot
  • 2. Drivers of the Lung Cancer Screening Software Market: impact analysis
  • 3. North America Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 4. North America Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 5. North America Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 6. North America Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 7. North America Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 8. U.S. Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 9. U.S. Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 10. U.S. Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 11. U.S. Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 12. U.S. Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 13. Canada Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 14. Canada Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 15. Canada Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 16. Canada Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 17. Canada Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 18. Europe Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 19. Europe Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 20. Europe Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 21. Europe Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 22. Europe Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 23. Germany Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 24. Germany Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 25. Germany Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 26. Germany Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 27. Germany Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 28. France Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 29. France Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 30. France Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 31. France Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 32. France Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 33. U.K. Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 34. U.K. Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 35. U.K. Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 36. U.K. Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 37. U.K. Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 38. Italy Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 39. Italy Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 40. Italy Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 41. Italy Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 42. Italy Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 43. Spain Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 44. Spain Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 45. Spain Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 46. Spain Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 47. Spain Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 48. Rest of Europe Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 49. Rest of Europe Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 50. Rest of Europe Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 51. Rest of Europe Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 52. Rest of Europe Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 53. Asia Pacific Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 54. Asia Pacific Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 55. Asia Pacific Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 56. Asia Pacific Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 57. Asia Pacific Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 58. China Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 59. China Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 60. China Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 61. China Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 62. China Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 63. Japan Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 64. Japan Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 65. Japan Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 66. Japan Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 67. Japan Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 68. India Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 69. India Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 70. India Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 71. India Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 72. India Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 73. South Korea Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 74. South Korea Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 75. South Korea Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 76. South Korea Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 77. South Korea Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 78. South-East Asia Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 79. South-East Asia Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 80. South-East Asia Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 81. South-East Asia Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 82. South-East Asia Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 83. Rest of Asia Pacific Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 84. Rest of Asia Pacific Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 85. Rest of Asia Pacific Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 86. Rest of Asia Pacific Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 87. Rest of Asia Pacific Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 88. Latin America Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 89. Latin America Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 90. Latin America Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 91. Latin America Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 92. Latin America Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 93. Brazil Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 94. Brazil Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 95. Brazil Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 96. Brazil Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 97. Brazil Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 98. Mexico Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 99. Mexico Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 100. Mexico Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 101. Mexico Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 102. Mexico Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 103. Rest of Latin America Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 104. Rest of Latin America Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 105. Rest of Latin America Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 106. Rest of Latin America Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 107. Rest of Latin America Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 108. The Middle-East and Africa Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 109. The Middle-East and Africa Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 110. The Middle-East and Africa Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 111. The Middle-East and Africa Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 112. The Middle-East and Africa Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 113. GCC Countries Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 114. GCC Countries Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 115. GCC Countries Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 116. GCC Countries Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 117. GCC Countries Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 118. South Africa Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 119. South Africa Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 120. South Africa Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 121. South Africa Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 122. South Africa Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)
  • 123. Rest of Middle-East Africa Lung Cancer Screening Software Market revenue, By Mode of Delivery, 2025 - 2034 (USD Million)
  • 124. Rest of Middle-East Africa Lung Cancer Screening Software Market revenue, By Product, 2025 - 2034 (USD Million)
  • 125. Rest of Middle-East Africa Lung Cancer Screening Software Market revenue, By Application, 2025 - 2034 (USD Million)
  • 126. Rest of Middle-East Africa Lung Cancer Screening Software Market revenue, By Platform, 2025 - 2034 (USD Million)
  • 127. Rest of Middle-East Africa Lung Cancer Screening Software Market revenue, By End-User, 2025 - 2034 (USD Million)

Methodology

FrequentlyAsked Questions

Lung cancer screening software is a modern application designed to automate the process of lung cancer screening.

The global lung cancer screening software market is expected to benefit from the rising prevalence of the disease.

According to study, the global lung cancer screening software market size was worth around USD 159.29 million in 2024 and is predicted to grow to around USD 650.4 million by 2034.

The CAGR value of lung cancer screening software market is expected to be around 16.63% during 2025-2034.

The global lung cancer screening software industry is projected to be challenged by lack of skilled professionals and regulatory complexities.

Market trends and consumer preferences  in the lung cancer screening software market are shifting toward cloud-based and AI-driven technologies.

The global lung cancer screening software market has performed well so far and will offer similar trends in the coming years.

Asia-Pacific is projected to emerge as the fastest-growing region with a CAGR of 16% during the forecast period.

The global lung cancer screening software market is led by players like MRS Systems Inc., Nuance Communications, Inc., Siemens Healthineers AG, Eon, MagView, Medtronic, GE HealthCare Technologies Inc., Coreline Soft Co., Ltd., Koninklijke Philips N.V., FUJIFILM Holdings Corporation, VoxelCloud, Optellum Ltd, HealthMyne, Qure.ai, and PenRad Technologies Inc.

The report explores crucial aspects of the lung cancer screening software market including detailed discussion of existing growth factors and restraints while also browsing future growth opportunities and challenges that impact the market.

  • zion payment modes

List of Contents

Lung Cancer Screening SoftwareIndustry Perspective:Key Insights:OverviewDynamicsReport ScopeSegmentationRegional AnalysisCompetitive AnalysisWhat are the latest key trends in the lung cancer screening software market?The global lung cancer screening software market is segmented as follows:

HappyClients